Medigen Vaccine Biologics (6547.TWO) Earnings Analysis
Medigen Vaccine Biologics (6547.TWO) next reports earnings on 2026-08-19, consensus EPS 0.06 TWD. Last quarter (2026-05-08) it missed with EPS -0.09 TWD vs 0.03 TWD est (-400%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -53.18.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6547.TWO next report earnings?
| Next earnings date | 2026-08-19 |
|---|---|
| Consensus EPS estimate | 0.06 TWD |
| Revenue estimate | 0.20B |
6547.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | -0.09 TWD | 0.03 TWD | -400% | Miss |
| 2026-03-12 | -0.42 TWD | 0.09 TWD | -566.7% | Miss |
| 2025-05-09 | -0.06 TWD | n/a | n/a | n/a |
| 2025-03-06 | -0.06 TWD | -0.01 TWD | -500% | Miss |
| 2024-11-04 | 0.00458 TWD | -0.32 TWD | +101.4% | Beat |
| 2024-08-01 | 0.04125 TWD | -0.34 TWD | +112.1% | Beat |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
6547.TWO valuation and analyst view
| Trailing P/E | -53.18 |
|---|---|
| Trailing EPS | -0.91784 TWD |
| Price / book | 4.19 |
| Dividend yield | 0.00% |
| Market cap | 15.63B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Medigen Vaccine Biologics (6547.TWO)'s next earnings date?
Medigen Vaccine Biologics is next scheduled to report on 2026-08-19, with a consensus EPS estimate of 0.06 TWD and revenue estimate of 0.20B.
Did 6547.TWO beat earnings last quarter?
In its 2026-05-08 report, 6547.TWO posted EPS of -0.09 TWD versus a 0.03 TWD estimate — a miss of 400%.
What is 6547.TWO's earnings track record?
Over the last 5 reported quarters with consensus data, 6547.TWO beat estimates 2 times (40%).
What is 6547.TWO's current P/E ratio and EPS?
6547.TWO trades at a trailing P/E of -53.18 on trailing EPS of -0.9178411956376755 TWD.
What do analysts rate 6547.TWO?
6547.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.